February 23, 2009 - Medtronic Inc. is acquiring CoreValve Inc., developer of a transcatheter, transfemoral aortic valve replacement product, and Ventor Technologies Ltd., a developer of transcatheter heart valve technologies for the treatment of aortic valve disease.

February 24, 2009 – Two U.S. healthcare facilities recently signed multiyear contracts with Siemens Healthcare for installation of Siemens’ Soarian Health Information System (HIS) platform.

An additional facility also signed a multiyear contract for Soarian and Siemens’ MedSeries4, another fully Web-based HIS designed to meet the needs of community hospitals.

Emageon’s HeartSuite 6.20.1 reported improvements include Web-based clinical reporting expanding reporting from any location, easier navigation and a consistent user interface across all reporting knowledge bases.

Vital Images’ Vitrea Web is a solution exclusive to ViTAL Enterprise customers that provides anywhere access to all of Vital Images’ powerful clinical applications.

February 23, 2009 - Neuisys Imaging System Solutions announced that the FDA has granted 510(k) clearance of the NeuViz 16, a multislice computed tomography (CT) system, which was developed by Philips Neusoft Medical Systems, a joint venture between Royal Philips Electronics of the Netherlands and Neusoft Corporation of China.

NovaRad and Digisonics' PACS/cardiovascular reporting system (CRS) aims to streamline the entire clinical reporting workflow and creates professional, standards-based reports for all cardiovascular modalities. Measurements, velocities, etc.

February 23, 2009 - AMICAS Inc. said today that they have entered into a definitive merger agreement to acquire Emageon Inc.

February 23, 2009 - Fresno Heart and Surgical Hospital of Fresno, CA today signed a trial agreement for Daxor Corp's Blood Volume Analyzer BVA-100, for its nuclear medicine department.

February 23, 2009 - Alsius Corp. said today it has signed an agreement with a subsidiary of ZOLL Medical Corp. under which Alsius will sell to ZOLL substantially all the assets constituting Alsius’ intravascular temperature management device business for a purchase price of $12 million in cash.

February 23, 2009 - Daiichi Sankyo Co. Ltd and Eli Lilly and Co. announced today that the European Commission granted marketing authorization for EFFIENT (prasugrel) for the prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) undergoing PCI.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now